Tesamorelin Effects on Liver Fat and Histology in HIV

Clinical trial NCT02196831 · COMPLETED

Trial details

NCT number: NCT02196831
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)

Start date: 2015-07-01
Primary completion: 2019-01-16
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.